PDCD1 and non-small cell lung carcinoma: reported a case of thyroid eye disease-like symptoms in a person with no history of thyroid disease that was caused by a nivolumab (Opdivo®: anti-PD-1 monoclonal antibody) treatment for non-small cell lung cancer (13).